Kunming Longjin Pharmaceutical News

Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.

00:00

Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.

Jun 4 00:00

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 30 00:00

Kunming Longjin Pharmaceutical: Response from China Audit Zhonghuan Certified Public Accountants (Special General Partnership) to the inquiry letter on the 2023 annual report of Kunming Longjin Pharmaceutical Co., Ltd.

May 28 00:00

Kunming Longjin Pharmaceutical: Notice of Response to the 2023 Annual Report Inquiry Letter

May 28 00:00

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 24 00:00

Kunming Longjin Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions

May 22 00:00

Kunming Longjin Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 22 00:00

Kunming Longjin Pharmaceutical: Notice of Serious Unusual Fluctuations in Stock Trading

May 21 00:00

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 16 00:00

Kunming Longjin Pharmaceutical: 002750*ST Longjin Investor Relations Management Information 20240514

May 14 13:30

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 13 00:00

Kunming Longjin Pharmaceutical: Announcement on participating in the 2023 Investor Online Group Reception Day for Listed Companies in Yunnan

May 9 00:00

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 8 00:00

Kunming Longjin Pharmaceutical: Summary report of the Board Audit Committee on the evaluation of the accounting firm's performance in 2023

May 6 00:00

Kunming Longjin Pharmaceutical: 2024-A004 Special Verification Report on the 2023 Operating Income Deduction Status Table

Apr 30 00:00

Kunming Longjin Pharmaceutical: Independent Director's 2023 Debriefing Report (Long Yungang)

Apr 30 00:00

Kunming Longjin Pharmaceutical: Independent Director's 2023 Debriefing Report (Sun Handong)

Apr 30 00:00

Kunming Longjin Pharmaceutical: Notice on changes in accounting policies

Apr 30 00:00

Kunming Longjin Pharmaceutical: Special instructions on the proposed non-distribution of profits in 2023

Apr 30 00:00